Search Results - "Fux, R."

Refine Results
  1. 1

    Reconsideration of the diagnostic criteria required for PCV2 reproductive disease by Unterweger, C., Brunthaler, R., Auer, A., Fux, R., Weissenbacher-Lang, C., Ladinig, A.

    Published in The veterinary journal (1997) (01-06-2021)
    “…•PCV2d is associated with abortions, mummifications and fetal autolysis in sows.•Confirmation of PCV2 reproductive disease (PCV2-RD) relies on a diagnostic…”
    Get full text
    Journal Article
  2. 2

    Low prevalence of porcine circovirus type 2 infections in farrowing sows and corresponding pre-suckling piglets in southern German pig farms by Eddicks, M., Koeppen, M., Willi, S., Fux, R., Reese, S., Sutter, G., Stadler, J., Ritzmann, M.

    Published in Veterinary microbiology (01-05-2016)
    “…•Amazingly low PCV2-sero prevalence in farrowing sows and pre-suckling piglets in southern Germany.•PCV2-excretion by the sows is rare at time of…”
    Get full text
    Journal Article
  3. 3

    Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany by Eddicks, M., Fux, R., Szikora, F., Eddicks, L., Majzoub-Altweck, M., Hermanns, W., Sutter, G., Palzer, A., Banholzer, E., Ritzmann, M.

    Published in Veterinary microbiology (17-04-2015)
    “…•First report about new emerging PCV2b-1C strains in German domestic pigs.•German PCV2b-1C strains show considerable differences in full genome sequences to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers by Fux, R, Kloor, D, Hermes, M, Röck, T, Proksch, B, Grenz, A, Delabar, U, Bücheler, R, Igel, S, Mörike, K, Gleiter, C H, Osswald, H

    “…Homocysteine is a precursor of S-adenosylmethionine (AdoMet) and a metabolite of S-adenosylhomocysteine (AdoHcy). The ratio of AdoMet to AdoHcy, defined as the…”
    Get more information
    Journal Article
  6. 6

    Gas Dynamics in the Galactic Bar Region from N-Body and SPH Simulations by Fux, R

    Published in Astrophysics and space science (01-01-2001)
    “…Self-consistent hybrid N-body and SPH simulations are used to give anew and coherent interpretation of the main features standing out from the HI and CO…”
    Get full text
    Journal Article
  7. 7
  8. 8

    New constraints on a triaxial model of the Galaxy by Sevenster, Maartje, Saha, Prasenjit, Valls-Gabaud, David, Fux, Roger

    “…We determine the most likely values of the free parameters of an N-body model for the Galaxy developed by Fux via a discrete-discrete comparison with the…”
    Get full text
    Journal Article
  9. 9

    Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety by Fux, R, Greiner, D, Geldmacher, M, Mörike, K, Gleiter, C H

    “…An increased number of drugs used by patients enhances the risk of potentially hazardous drug interactions. So far, no representative data are available about…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pharmacokinetics and safety of Roflumilast, a once-daily, oral, selective PDE4 inhibitor, and its active metabolite Roflumilast N-oxide in healthy subjects by Huennemeyer, A., Hauns, B., David, M., Böhmer, G., Fux, R., Gleiter, C.H., Waitzinger, J., Zech, K., Bethke, T.D.

    Published in Journal of allergy and clinical immunology (01-02-2004)
    “…Roflumilast is a novel, potent, selective phosphodiesterase 4 (PDE4) inhibitor in clinical development for the treatment of chronic obstructive pulmonary…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pharmacogenetics of antimalarial drugs: effect on metabolism and transport by Kerb, Reinhold, Dr, Fux, Richard, MD, Mörike, Klaus, MD, Kremsner, Peter G, MD, Gil, José Pedro, PhD, Gleiter, Christoph H, MD, Schwab, Matthias, MD

    Published in The Lancet infectious diseases (01-12-2009)
    “…Summary The prevention and management of malaria is primarily based on the use of drugs. Clinical trials have however revealed that between individuals there…”
    Get full text
    Journal Article
  14. 14

    Effect of urea and osmotic cell shrinkage on Ca2+ entry and contraction of vascular smooth muscle cells by Wagner, C A, Huber, S M, Wärntges, S, Zempel, G, Kaba, N K, Fux, R, Orth, N, Busch, G L, Waldegger, S, Lambert, I, Nilius, B, Heinle, H, Lang, F

    Published in Pflügers Archiv (01-06-2000)
    “…The present study was performed to elucidate the effects of urea on vascular smooth muscle cells (SMC). Addition of urea (20, 50, 100 mM) to physiological salt…”
    Get full text
    Journal Article
  15. 15

    Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: A prospective clinical study by Fux, Richard, Mörike, Klaus, Pröhmer, Anne M.T., Delabar, Ursula, Schwab, Matthias, Schaeffeler, Elke, Lorenz, Gernot, Gleiter, Christoph H., Eichelbaum, Michel, Kivistö, Kari T.

    Published in Clinical pharmacology and therapeutics (01-10-2005)
    “…Objective Our objective was to study the impact of the cytochrome P450 (CYP) 2D6 polymorphism on the tolerability of metoprolol in a real‐life primary care…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Dose-Proportional Intraindividual Single- and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor by Bethke, Thomas D., Böhmer, Gabriele M., Hermann, Robert, Hauns, Bernhard, Fux, Richard, Mörike, Klaus, David, Michael, Knoerzer, Dietrich, Wurst, Wilhelm, Gleiter, Christoph H.

    Published in Journal of clinical pharmacology (01-01-2007)
    “…The dose‐proportional, intraindividual, single‐ and repeated‐dose pharmacokinetics of roflumilast, an oral, once‐daily phosphodiesterase 4 inhibitor under…”
    Get full text
    Journal Article
  18. 18

    Identification of Urinary Modified Nucleosides and Ribosylated Metabolites in Humans Via Combined ESI-FTICR MS and ESI-IT MS Analysis by Bullinger, Dino, Fux, Richard, Nicholson, Graeme, Plontke, Stefan, Belka, Claus, Laufer, Stefan, Gleiter, Christoph H., Kammerer, Bernd

    “…The physiological response of the human body to several diseases can be reflected by the metabolite pattern in biological fluids. Cancer, like other diseases…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival by FUX, Richard, SCHWAB, Matthias, THON, Klaus-Peter, GLEITER, Christoph H, FRITZ, Peter

    Published in Clinical cancer research (01-07-2005)
    “…Purpose: Cyclooxygenase-2 (COX-2) expression in human colorectal cancer and adenoma tissue seems to be higher than in normal mucosa. However, data about the…”
    Get full text
    Journal Article